Year-end Sale % OFF 
Abstract
Background: Gastro esophageal reflux disease (GERD), a highly prevalent disorder has adverse impact on quality of life. An estimated 40% of GERD patients have incomplete response to standard PPI therapy. For these PPI refractory patients, doubling the PPI dose or switching to another PPI are pursued by the treating physicians that might not be optimal. Therefore, an appropriate second line treatment should focus on addition of gastro-prokinetic drugs that stimulates gastric motility.Materials & Methods: This was a prospective observational study conducted in 118 patients suffering from symptoms suggestive of GERD, at four centers in Indian National Capital region to assess the overlap between GERD and delayed gastric emptying and to predict the need for combination therapy of PPI with pro-kinetic drug using Frequency Scale for the Symptoms of GERD (FSSG) score.Results: The mean total FSSG score was 16.37 ± 7.50. From 118 patients, 98 (83.05%) met the criteria for GERD with FSSG total score more than eight. The mean reflux score was 7.43 ± 4.08, while the mean dysmotility score was 8.94 ± 4.83. GERD patients in this study have a high mean FSSG score, whereas dysmotility symptoms proved to be more dominant than acid reflux.Conclusion: Based on the findings of this study, combination therapy of PPI with prokinetics is recommended in subsets of patients with high FSSG scoreJ MEDICINE JUL 2018; 19 (2) : 74-78
Highlights
Gastroesophageal reflux disease (GERD) is a chronic condition which develops when the reflux of stomach contents cause troublesome symptoms and/or complications.[1]
Inclusion Criteria: Ambulatory patients aged between 18 to 65 years, and at least a 3-month history of symptoms suggestive of Gastro esophageal reflux disease (GERD) and/or delayed gastric emptying were eligible for inclusion in this study
GERD patients in this study have a high mean FSSG score, suggesting that dysmotility symptoms are more dominant than acid reflux
Summary
Gastroesophageal reflux disease (GERD) is a chronic condition which develops when the reflux of stomach contents cause troublesome symptoms and/or complications.[1] The prevalence of GERD in India ranges from 8-20% according to recently conducted studies based on different case definitions and study methodology.[2] The subtypes of GERD include erosive esophagitis (EE), nonerosive reflux disease (NERD) and Barrett’s esophagus. Gastro esophageal reflux disease (GERD), a highly prevalent disorder has adverse impact on quality of life.An estimated 40% of GERD patients have incomplete response to standard PPI therapy. For these PPI refractory patients, doubling the PPI dose or switching to another PPI are pursued by the treating physicians that might not be optimal. An appropriate second line treatment should focus on addition of gastro-prokinetic drugs that stimulates gastric motility
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
